Treatment of eosinophilic esophagitis with inhaled corticosteroids.
Department of Pediatrics, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
W A
WA
Faubion
J
J
Perrault
L J
LJ
Burgart
N N
NN
Zein
M
M
Clawson
D K
DK
Freese
D000280:Administration, Inhalation; D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000730:Androstadienes / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents; D001507:Beclomethasone / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D004802:Eosinophilia / Q000473:pathology; D004941:Esophagitis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D000068298:Fluticasone; D005938:Glucocorticoids; D006801:Humans; D008297:Male
D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D000068298:Fluticasone; D001507:Beclomethasone